Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NGLFINE.NSE
- Price
- 1406.20
- Stock movement up
- +74.30 (5.58%)
- Company name
- NGL Fine-Chem Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - General
- Market cap
- 8.69B
- Ent value
- 10.51B
- Price/Sales
- 2.13
- Price/Book
- 2.89
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 42.00
- Forward P/E
- -
- PEG
- -
- EPS growth
- 20.44%
- 1 year return
- -21.97%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-31
DIVIDENDS
NGLFINE.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 42.00 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 48.46 |
| EV to EBITDA | 58.62 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.13 |
| Price to Book | 2.89 |
| EV to Sales | 2.57 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 6.18M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 19.02M |
| Net receivables | 1.13B |
| Total current assets | 2.66B |
| Goodwill | 1.53M |
| Intangible assets | 3.61M |
| Property, plant and equipment | 2.05B |
| Total assets | 4.84B |
| Accounts payable | 716.43M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.41B |
| Total liabilities | 1.84B |
| Shareholder's equity | 3.00B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1325.00 |
| Daily high | 1433.90 |
| Daily low | 1316.80 |
| Daily Volume | 4K |
| All-time high | 2714.45 |
| 1y analyst estimate | - |
| Beta | 0.20 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 12 Aug 2025 |
| Next earnings date | 5 Feb 2026 |
Downside potential
Loading...
Downside potential data
| NGLFINE.NSE | S&P500 | |
| Current price drop from All-time high | -48.20% | -1.23% |
| Highest price drop | -63.78% | -19.00% |
| Date of highest drop | 18 Feb 2025 | 8 Apr 2025 |
| Avg drop from high | -47.13% | -2.58% |
| Avg time to new high | - | 6 days |
| Max time to new high | 311 days | 89 days |
COMPANY DETAILS
Marketcap
8.69B
Marketcap category
Mid-cap
Description
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Employees
520
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found